duracef ds powder for suspension
navana pharmaceuticals ltd. - cefixime - powder for suspension - 200 mg/5 ml
duracef - max powder for suspension
navana pharmaceuticals ltd. - cefixime - powder for suspension - 500 mg/5 ml
duricef 125 mg/5ml powder for oral susp.
smithkline beecham-egypt - powder for oral suspension - 125 mg/5ml
duricef 250 mg/5ml susp.
smithkline beecham-egypt - powder for oral suspension - 250 mg/5ml
duricef 500mg /5ml susp.
smithkline beecham-egypt - powder for oral suspension - 500 mg/5ml
duricef paediatric 100mg/ml oral drops
bristol-myers squibb-usa - powder for oral suspension - 100 mg/ml
duracef 500 mg/5 ml or. susp. (pwdr.)
bausch health ireland ltd. - cefadroxil monohydrate 171,429 mg - powder for oral suspension - 500 mg/5 ml - cefadroxil 176.57 mg/g - cefadroxil
duracef 250 mg/5 ml or. susp. (pwdr.)
bausch health ireland ltd. - cefadroxil monohydrate 85,7154 mg - powder for oral suspension - 250 mg/5 ml - cefadroxil 88.29 mg/g - cefadroxil
duride
viatris limited - isosorbide mononitrate 60mg - modified release tablet - 60 mg - active: isosorbide mononitrate 60mg excipient: aluminium silicate colloidal silicon dioxide hard paraffin magnesium stearate microcrystalline cellulose opadry yellow oy-ls-22814 - prophylaxis of angina pectoris. duride is not recommended for the management of acute attacks of angina pectoris.
duracef 1 g dispersible tablet
bm_squib -